Home >> Research Area >>Natural Products>>Diterpenoids>> 16-Kaurene-2,6,15-triol

16-Kaurene-2,6,15-triol

CAS# 53452-32-7

16-Kaurene-2,6,15-triol

Catalog No. BCN5706----Order now to get a substantial discount!

Product Name & Size Price Stock
16-Kaurene-2,6,15-triol: 5mg $886 In Stock
16-Kaurene-2,6,15-triol: 10mg Please Inquire In Stock
16-Kaurene-2,6,15-triol: 20mg Please Inquire Please Inquire
16-Kaurene-2,6,15-triol: 50mg Please Inquire Please Inquire
16-Kaurene-2,6,15-triol: 100mg Please Inquire Please Inquire
16-Kaurene-2,6,15-triol: 200mg Please Inquire Please Inquire
16-Kaurene-2,6,15-triol: 500mg Please Inquire Please Inquire
16-Kaurene-2,6,15-triol: 1000mg Please Inquire Please Inquire

Quality Control of 16-Kaurene-2,6,15-triol

Number of papers citing our products

Chemical structure

16-Kaurene-2,6,15-triol

3D structure

Chemical Properties of 16-Kaurene-2,6,15-triol

Cas No. 53452-32-7 SDF Download SDF
PubChem ID 73554068 Appearance Powder
Formula C20H32O3 M.Wt 320.5
Type of Compound Diterpenoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (1R,4S,9R,10R,13R)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-3,7,15-triol
SMILES CC1(CC(CC2(C1C(CC34C2CCC(C3)C(=C)C4O)O)C)O)C
Standard InChIKey OUDUFOYDAUOXPD-UZHLRENFSA-N
Standard InChI InChI=1S/C20H32O3/c1-11-12-5-6-15-19(4)9-13(21)8-18(2,3)16(19)14(22)10-20(15,7-12)17(11)23/h12-17,21-23H,1,5-10H2,2-4H3/t12-,13?,14?,15-,16+,17?,19-,20-/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of 16-Kaurene-2,6,15-triol

The herbs of Rabdosia amethystoides

16-Kaurene-2,6,15-triol Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

16-Kaurene-2,6,15-triol Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 16-Kaurene-2,6,15-triol

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.1201 mL 15.6006 mL 31.2012 mL 62.4025 mL 78.0031 mL
5 mM 0.624 mL 3.1201 mL 6.2402 mL 12.4805 mL 15.6006 mL
10 mM 0.312 mL 1.5601 mL 3.1201 mL 6.2402 mL 7.8003 mL
50 mM 0.0624 mL 0.312 mL 0.624 mL 1.248 mL 1.5601 mL
100 mM 0.0312 mL 0.156 mL 0.312 mL 0.624 mL 0.78 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 16-Kaurene-2,6,15-triol

Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities.[Pubmed:29024590]

ACS Comb Sci. 2017 Dec 11;19(12):748-754.

A novel three-component, two-step, one-pot nucleophilic aromatic substitution (SNAr)-intramolecular cyclization-Suzuki coupling reaction was developed for the synthesis of benzo[h][1,6]naphthyridin-2(1H)-ones (Torins). On the basis of the new efficiently convergent synthetic route, a library of Torin analogs was synthesized. The antimalarial activities of these compounds were evaluated against asexual parasites using a growth inhibition assay and gametocytes using a viability assay.

Intelligence and all-cause mortality in the 6-Day Sample of the Scottish Mental Survey 1947 and their siblings: testing the contribution of family background.[Pubmed:29025063]

Int J Epidemiol. 2018 Feb 1;47(1):89-96.

Background: Higher early-life intelligence is associated with a reduced risk of mortality in adulthood, though this association is apparently hardly attenuated when accounting for early-life socio-economic status (SES). However, the use of proxy measures of SES means that residual confounding may underestimate this attenuation. In the present study, the potential confounding effect of early-life SES was instead accounted for by examining the intelligence-mortality association within families. Methods: The association between early-life intelligence and mortality in adulthood was assessed in 727 members of the 6-Day Sample of the Scottish Mental Survey 1947 and, for the first time, 1580 of their younger siblings. These individuals were born between 1936 and 1958, and were followed up into later life, with deaths recorded up to 2015. Cox regression was used to estimate the relative risk of mortality associated with higher IQ scores after adjusting for shared family factors. Results: A standard-deviation advantage in IQ score was associated with a significantly reduced mortality risk [hazard ratio = 0.76, p < 0.001, 95% confidence interval (CI) (0.68-0.84)]. This reduction in hazard was only slightly attenuated by adjusting for sex and shared family factors [hazard ratio = 0.79, p = 0.002, 95% CI (0.68-0.92)]. Conclusions: Although somewhat conservative, adjusting for all variance shared by a family avoids any potential residual confounding of the intelligence-mortality association arising from the use of proxy measures of early-life SES. The present study demonstrates that the longevity associated with higher early-life intelligence cannot be explained by early-life SES or within-family factors.

Functional interleukin-6 receptor-alpha is located in tanycytes at the base of the third ventricle.[Pubmed:29024103]

J Neuroendocrinol. 2017 Dec;29(12).

Interleukin (IL)-6(-) /(-) mice develop mature onset obesity, whereas i.c.v. injection of IL-6 decreases obesity in rodents. Moreover, levels of IL-6 in cerebrospinal fluid (CSF) were reported to be inversely correlated with obesity in humans. Tanycytes lining the base of the third ventricle (3V) in the hypothalamus have recently been reported to be of importance for metabolism. In the present study, we investigated whether tanycytes could respond to IL-6 in the CSF. With immunohistochemistry using a well characterised antibody directed against the ligand binding receptor for IL-6, IL-6 receptor alpha (IL-6Ralpha), it was found that tanycytes, identified by the two markers, vimentin and dopamine- and cAMP-regulated phosphoprotein of 32 kDa, contained IL-6Ralpha. There were fewer IL-6Ralpha on another type of ventricle-lining cells, ependymal cells, as identified by the marker glucose transporter-1. To demonstrate that the immunoreactive IL-6Ralpha were responsive to IL-6, we injected IL-6 i.c.v. This treatment increased immunoreactive phosphorylated signal transducer and activator of transcription-3 (pSTAT3) in tanycytes after 5 minutes and in cells in the medial part of the arcuate nucleus after 5 and 15 minutes. Intracerebroventricular injection of leptin exerted similar effects. As expected, i.p. injection of leptin also induced pSTAT3 staining in the hypothalamus, whereas i.p. IL-6 injection had little effect on this parameter. Intracerebroventricular or i.p. injection of vehicle only had no effect on pSTAT3-immunoreactivity. In summary, there are functional IL-6Ralpha on tanycytes at the bottom of the 3V, in agreement with the possibility that ventricular administration of IL-6 decreases obesity in mice via an effect on this cell type.

Keywords:

16-Kaurene-2,6,15-triol,53452-32-7,Natural Products, buy 16-Kaurene-2,6,15-triol , 16-Kaurene-2,6,15-triol supplier , purchase 16-Kaurene-2,6,15-triol , 16-Kaurene-2,6,15-triol cost , 16-Kaurene-2,6,15-triol manufacturer , order 16-Kaurene-2,6,15-triol , high purity 16-Kaurene-2,6,15-triol

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: